CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q2 2017 13F Holders as of 30 Jun 2017
- Type / Class
- Equity / Common stock
- Shares outstanding
- 15,075,924
- Total 13F shares
- 5,449,601
- Share change
- -56,161
- Total reported value
- $38,275,000
- Price per share
- $7.00
- Number of holders
- 33
- Value change
- -$394,992
- Number of buys
- 13
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230770109:
Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARIEL INVESTMENTS, LLC |
13F
|
Company |
9.2%
|
1,393,125
|
$9,668,000 | — | 31 Mar 2017 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
5.7%
|
863,819
|
$5,995,000 | — | 31 Mar 2017 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
4.9%
|
739,917
|
$5,135,000 | — | 31 Mar 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.8%
|
418,627
|
$2,904,000 | — | 31 Mar 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
297,455
|
$2,064,000 | — | 31 Mar 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
2%
|
294,275
|
$2,042,000 | — | 31 Mar 2017 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
293,700
|
$2,038,000 | — | 31 Mar 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.8%
|
270,240
|
$1,875,000 | — | 31 Mar 2017 | |
| JW Asset Management, LLC |
13F
|
Company |
1.8%
|
263,881
|
$1,830,000 | — | 31 Mar 2017 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.87%
|
130,430
|
$905,000 | — | 31 Mar 2017 | |
| BARD ASSOCIATES INC |
13F
|
Company |
0.59%
|
88,565
|
$615,000 | — | 31 Mar 2017 | |
| Invesco Ltd. |
13F
|
Company |
0.46%
|
70,090
|
$486,000 | — | 31 Mar 2017 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.36%
|
53,800
|
$373,000 | — | 31 Mar 2017 | |
| EAGLE GLOBAL ADVISORS LLC |
13F
|
Company |
0.35%
|
52,767
|
$366,000 | — | 31 Mar 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.35%
|
52,092
|
$361,000 | — | 31 Mar 2017 | |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC |
13F
|
Company |
0.24%
|
36,626
|
$254,000 | — | 31 Mar 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
25,726
|
$178,000 | — | 31 Mar 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.16%
|
23,812
|
$165,000 | — | 31 Mar 2017 | |
| Spark Investment Management LLC |
13F
|
Company |
0.15%
|
22,600
|
$156,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.14%
|
21,615
|
$150,000 | — | 31 Mar 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
20,338
|
$141,000 | — | 31 Mar 2017 | |
| DELTA ASSET MANAGEMENT LLC/TN |
13F
|
Company |
0.08%
|
12,000
|
$83,000 | — | 31 Mar 2017 | |
| TFS CAPITAL LLC |
13F
|
Company |
0.08%
|
11,499
|
$80,000 | — | 31 Mar 2017 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.07%
|
10,945
|
$76,000 | — | 31 Mar 2017 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.07%
|
10,550
|
$73,000 | — | 31 Mar 2017 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.07%
|
10,000
|
$69,000 | — | 31 Mar 2017 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.03%
|
5,198
|
$36,000 | — | 31 Mar 2017 | |
| Nationwide Fund Advisors |
13F
|
Company |
0.03%
|
3,851
|
$27,000 | — | 31 Mar 2017 | |
| Oakworth Capital, Inc. |
13F
|
Company |
0.02%
|
3,052
|
$21,000 | — | 31 Mar 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
2,072
|
$13,000 | — | 31 Mar 2017 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,402
|
$10,000 | — | 31 Mar 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
672
|
$5,000 | — | 31 Mar 2017 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0%
|
583
|
$4,000 | — | 31 Mar 2017 | |
| Walleye Trading LLC |
13F
|
Company |
0%
|
438
|
$3,000 | — | 31 Mar 2017 | |
| MUFG Americas Holdings Corp |
13F
|
Company |
0%
|
230
|
$2,000 | — | 31 Mar 2017 | |
| THOMPSON DAVIS & CO., INC. |
13F
|
Company |
0%
|
200
|
$1,000 | — | 31 Mar 2017 |
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q2 2017
As of 30 Jun 2017,
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,449,601 shares.
The largest 10 holders included
Stonepine Capital Management, LLC, ARIEL INVESTMENTS, LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, RENAISSANCE TECHNOLOGIES LLC, NEW YORK STATE COMMON RETIREMENT FUND, JW Asset Management, LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
34
Q2 2017 holders
33
Holder diff
-1
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.